Ariad Pharmaceuticals (ARIA)

Add to Watchlists Create an Alert
18.43 +0.90  +5.13%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Ariad Pharmaceuticals Return on Equity:

-103.4% for Dec. 31, 2012
View Full Chart

Ariad Pharmaceuticals Return on Equity Chart

    Ariad Pharmaceuticals Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -103.4%
    Dec. 31, 2012 -114.3%
    Sept. 30, 2012 -120.5%
    June 30, 2012 -100.2%
    March 31, 2012 -125.4%
    Dec. 31, 2011 -166.5%
    Sept. 30, 2011 -273.8%
    June 30, 2011 -318.2%
    March 31, 2011 369.6%
    Dec. 31, 2010
    Sept. 30, 2010
    June 30, 2010
    March 31, 2010
    Dec. 31, 2009
    Sept. 30, 2009
    June 30, 2009
    March 31, 2009
    Dec. 31, 2008
    Sept. 30, 2008
    June 30, 2008
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    ARIA Return on Equity Benchmarks

    Companies
    Array BioPharma
    Celldex Therapeutics -53.87%
    Infinity Pharmaceuticals -53.02%

    ARIA Return on Equity Rankings

    Overall 44th percentile
    4444 of 8005
    Sector 36th percentile
    434 of 686 in Healthcare
    Industry 50th percentile
    123 of 248 in Biotechnology

    ARIA Return on Equity Range, Past 5 Years

    Minimum -318.2% Jun 2011
    Maximum 369.6% Mar 2011
    Average -105.9%